The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life analysis of NCCTG N0877 (Alliance): Phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM).
 
Rui Qin
Employment - Munich Reinsurance America (I)
Stock and Other Ownership Interests - United Health Group (I)
 
Angelina D. Tan
No Relationships to Disclose
 
Jeff A. Sloan
No Relationships to Disclose
 
Derek Richard Johnson
No Relationships to Disclose
 
Glenn Jay Lesser
Honoraria - Merck
Consulting or Advisory Role - Abbvie; Stemline Therapeutics
Research Funding - Celldex; ImmunoCellular Therapeutics; Northwest Biotherapeutics
 
S. Keith Anderson
Patents, Royalties, Other Intellectual Property - Mayo Clinic
 
Nadia N. Laack
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb (Inst)